Mark A. Burnett, Director at ProPhase Labs, Inc. (PRPH), bought 100 shares at $0.85 ($85) on 2011-08-23, disclosed to the SEC on 2011-08-25.
Open-market purchase of $85 PRPH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.